Dr. Travis Wheeler and his research group use computational methods to advance genome research, drug discovery, and precision medicine.

BIO5 member Katharina Schimmel is advancing research on hereditary hemorrhagic telangiectasia, a genetic disease that causes dangerous blood vessel malformations. Her work aims to improve early diagnosis and uncover new treatment options.

BIO5 member John Elfar led a UArizona study showing the multiple sclerosis drug 4-aminopyridine accelerates bone fracture healing in mice. The drug boosted BMP2 activity, bone mass, and osteoblast growth, suggesting potential for faster, stronger recovery in future clinical applications.